Submit Deal

Tiberend Strategic Advisors

Summary

Tiberend Strategic Advisors is a full service investor and corporate communications firm specializing in the healthcare and life sciences industry.

Market Context

Deals Overview

Edit Data

Total Deals6

Valued Deals3

Total Value£ 402 M

Avg. Deal Size£ 134 M

30 Mar 2023|United States|Biotechnology

Target: DIFFUSION PHARMACEUTICALS

Bidder: EIP PHARMA

7 Service Providers

4 Target | 3 Bidder

10 Dealmakers

9 Target | 1 Bidder

n/a

Value

09 Jun 2022|Singapore|Biotechnology

Target: TESSA THERAPEUTICS PTE LTD

Bidder: HELICONIA CAPITAL

7 Service Providers

2 Target | 5 Bidder

11 Dealmakers

5 Target | 6 Bidder

£ 102 M

Value

19 Apr 2022|United States|Pharmaceuticals

Target: COEPTIS THERAPEUTICS

Bidder: BULL HORN HOLDINGS CORP

10 Service Providers

4 Target | 6 Bidder

18 Dealmakers

4 Target | 14 Bidder

£ 134 M

Value

13 Sep 2021|United States|Pharmaceuticals

Target: FIRST WAVE BIO

Bidder: AZURRX BIOPHARMA

4 Service Providers

2 Target | 2 Bidder

19 Dealmakers

13 Target | 6 Bidder

£ 165 M

Value

19 Oct 2020|United States|Pharmaceuticals

Target: CLEVELAND BIOLABS

Bidder: CYTOCOM

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

1 Target | 5 Bidder

n/a

Value

20 Jul 2020|United States|Biotechnology

Target: IMQUEST LIFE SCIENCES

Bidder: CYTOCOM

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

1 Target | 4 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy